Point-of-Care Coagulation Testing (POCCT) is transforming healthcare by delivering rapid, bedside analysis of blood clotting, enabling clinicians to make immediate, data-driven decisions. The growing need for fast and accurate coagulation diagnostics—especially for personalized care in emergencies, surgeries, and bleeding disorders—is driving market growth. Innovations in device miniaturization, connectivity, and AI integration are further accelerating adoption. Advanced viscoelastic testing is gaining traction, providing a comprehensive clot profile that improves trauma and surgical outcomes. Expanding home-based anticoagulant monitoring represents a significant opportunity, empowering patients with chronic conditions to manage therapy conveniently. Governments are also supporting this shift: for example, the U.S. National Institutes of Health (NIH) allocated over USD 25 million in 2024 for POC diagnostic research, while the European Union’s Horizon Europe program funds projects to improve decentralized and rapid coagulation testing. Nonetheless, maintaining consistent quality control outside centralized laboratory settings remains a key challenge for the market.
Point-of-Care Coagulation Testing Market, By Test Type (Prothrombin Time (PT/INR) Testing, Activated Clotting Time (ACT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, and Viscoelastic Testing (TEG, ROTEM, etc.)), By Technology, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4467
|
Published Date
November 2025
|
Pages
390
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Point-of-Care Coagulation Testing Market size was valued at US$ 2,798.78 Million in 2024, expanding at a CAGR of 6.5% from 2025 to 2032.
Point-of-Care Coagulation Testing Market- Market Dynamics
Rising Prevalence of Cardiovascular Diseases
Cardiovascular diseases (CVDs) such as deep vein thrombosis, stroke, and atrial fibrillation remain leading causes of death and morbidity worldwide. According to the World Health Organization (WHO) July 2025 report, CVDs were the primary cause of global mortality, accounting for approximately 19.8 million deaths in 2022—about 32% of total deaths. Heart attacks and strokes were responsible for 85% of these fatalities. Furthermore, CVDs contributed to at least 38% of the 18 million premature deaths (under age 70) from noncommunicable diseases in 2021. Effective anticoagulation therapy is essential to prevent potentially fatal complications such as bleeding or thrombosis, requiring regular monitoring of clotting parameters including Prothrombin Time (PT/INR) and Activated Clotting Time (ACT). Traditional laboratory testing, however, is often hindered by centralized infrastructure and long turnaround times, which can delay critical treatment decisions. Point-of-Care (POC) coagulation testing addresses these challenges by delivering rapid results at the patient’s bedside, in operating rooms, emergency departments, or even at home. This not only reduces hospitalizations but also enhances patient adherence, particularly among long-term anticoagulant users.
Point-of-Care Coagulation Testing Market- Key Insights
- According to our research analysis, the global Point-of-Care Coagulation Testing (POCCT) market is projected to grow at a CAGR of approximately 6.5% during the forecast period from 2025 to 2032.
- By test type, Prothrombin Time (PT/INR) testing is expected to hold the largest market share in 2024.
- In terms of technology, optical-based testing leads the market in 2024.
- Regarding end users, hospitals and clinics are anticipated to dominate the market in 2024.
- Geographically, North America is projected to be the largest revenue generator in 2024.
Point-of-Care Coagulation Testing Market- Segmentation Analysis:
The Global Point-of-Care Coagulation Testing Market is segmented on the basis of Test Type, Technology, End User, and Region.
The market for coagulation testing is divided by test type into five core categories: Prothrombin Time (PT/INR) Testing, Activated Clotting Time (ACT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, Viscoelastic Testing (TEG/ROTEM), and Other Specialized Coagulation Tests. PT/INR testing remains the most widely adopted, due to its critical role in monitoring anticoagulation therapy (such as warfarin) and assessing liverfunction related clotting disorders—one report indicates PT testing held approximately 25.4% of the revenue share of coagulation analyzer test types in 2024. The ACT and aPTT tests follow, covering monitoring of highdose heparin and intrinsic pathway clotting respectively; meanwhile viscoelastic testing (TEG/ROTEM) is gaining traction in surgical and trauma settings due to its ability to assess clot dynamics in real time. The global coagulation testing market was valued around USD3.945billion in 2022 and is expected to more than double to USD9.699billion by 2030 at a CAGR of approximately 11.9%.
Credence Research Inc.
From the perspective of technology, the market is segmented into Optical Technology, Mechanical Technology, and Electrochemical Technology. Optical technologies—which measure changes in light transmission or scatter to detect clotting events—currently hold the largest share of the market thanks to their maturity and reliability. Mechanical technologies measure blood viscosity or movement (e.g., clot firmness or flow impediment) and are often used in viscoelastic tests, while electrochemical technologies detect electrical changes during coagulation reactions and are emerging as miniaturised or pointofcare solutions. According to a report, the global coagulation analyzer market (which encompasses these technologies) reached about USD6.2billion in 2024 and is forecast to reach USD11.4billion by 2033 at a CAGR of around 6.63%.
Point-of-Care Coagulation Testing Market- Competitive Landscape:
The point-of-care (POC) coagulation testing market is highly competitive and experiencing rapid growth, fueled by the rising need for fast and accurate clotting assessments in both clinical and home settings. Major players in the market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, and Werfen. These companies focus on expanding their product portfolios through advanced technologies such as microfluidics, biosensors, and AI integration. Significant investments in research, innovation, and strategic collaborations are enabling improvements in device accuracy, portability, and connectivity, facilitating seamless integration with healthcare systems. For example, in January 2022, F. Hoffmann-La Roche Ltd. launched the cobas pulse system in select countries with CE Mark approval, representing the latest generation of connected point-of-care solutions for professional blood glucose and coagulation management.
The market exhibits a semi-consolidated structure, with a few dominant manufacturers holding substantial shares while numerous smaller players compete in specialized niche segments.
Recent Developments:
- In July 2024, Werfen launched the GEM Premier 7000 with Intelligent Quality Management 3 (iQM3), a breakthrough in blood gas testing featuring hemolysis detection at the point-of-care for the first time.
- In March 2023, Siemens Healthineers and Sysmex Corporation signed a global Original Equipment Manufacturer (OEM) agreement to supply hemostasis instruments and reagents. This strengthened collaboration leveraged their 25-year partnership to advance hemostasis testing technology and improve patient outcomes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Siemens Healthineers
- Abbott Laboratories
- Sysmex Corporation
- Werfen
- Danaher Corporation
- Medtronic
- HemoSonics, LLC
- Danaher Corporation
- Trinity Biotech
- F. Hoffmann-La Roche Ltd
- Others
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Prothrombin Time (PT/INR) Testing
- Activated Clotting Time (ACT) Testing
- Activated Partial Thromboplastin Time (aPTT) Testing
- Viscoelastic Testing (TEG, ROTEM, etc.)
- Other Specialized Coagulation Tests
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Optical Technology
- Mechanical Technology
- Electrochemical Technology
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Ambulatory Surgical Centers (ASCs)
- Diagnostic Laboratories
- Home Care Settings
- Others
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Point-of-Care Coagulation Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Point-of-Care Coagulation Testing Market Snippet by Test Type
2.1.2. Point-of-Care Coagulation Testing Market Snippet by Technology
2.1.3. Point-of-Care Coagulation Testing Market Snippet by End User
2.1.4. Point-of-Care Coagulation Testing Market Snippet by Country
2.1.5. Point-of-Care Coagulation Testing Market Snippet by Region
2.2. Competitive Insights
3. Point-of-Care Coagulation Testing Key Market Trends
3.1. Point-of-Care Coagulation Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Point-of-Care Coagulation Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Point-of-Care Coagulation Testing Market Opportunities
3.4. Point-of-Care Coagulation Testing Market Future Trends
4. Point-of-Care Coagulation Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Point-of-Care Coagulation Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Point-of-Care Coagulation Testing Market Landscape
6.1. Point-of-Care Coagulation Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Point-of-Care Coagulation Testing Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
7.1.2. Prothrombin Time (PT/INR) Testing
7.1.3. Activated Clotting Time (ACT) Testing
7.1.4. Activated Partial Thromboplastin Time (aPTT) Testing
7.1.5. Viscoelastic Testing (TEG, ROTEM, etc.)
7.1.6. Other Specialized Coagulation Tests
8. Point-of-Care Coagulation Testing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. Optical Technology
8.1.3. Mechanical Technology
8.1.4. Electrochemical Technology
9. Point-of-Care Coagulation Testing Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Hospitals & Clinics
9.1.3. Ambulatory Surgical Centers (ASCs)
9.1.4. Diagnostic Laboratories
9.1.5. Home Care Settings
9.1.6. Others
10. Point-of-Care Coagulation Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Point-of-Care Coagulation Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Point-of-Care Coagulation Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Point-of-Care Coagulation Testing Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Point-of-Care Coagulation Testing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Point-of-Care Coagulation Testing Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Point-of-Care Coagulation Testing Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Siemens Healthineers
11.2.2. Abbott Laboratories
11.2.3. Sysmex Corporation
11.2.4. Werfen
11.2.5. Danaher Corporation
11.2.6. Medtronic
11.2.7. HemoSonics, LLC
11.2.8. Danaher Corporation
11.2.9. Trinity Biotech
11.2.10. F. Hoffmann-La Roche Ltd
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Siemens Healthineers
- Abbott Laboratories
- Sysmex Corporation
- Werfen
- Danaher Corporation
- Medtronic
- HemoSonics, LLC
- Danaher Corporation
- Trinity Biotech
- F. Hoffmann-La Roche Ltd
- Others
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Prothrombin Time (PT/INR) Testing
- Activated Clotting Time (ACT) Testing
- Activated Partial Thromboplastin Time (aPTT) Testing
- Viscoelastic Testing (TEG, ROTEM, etc.)
- Other Specialized Coagulation Tests
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Optical Technology
- Mechanical Technology
- Electrochemical Technology
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Ambulatory Surgical Centers (ASCs)
- Diagnostic Laboratories
- Home Care Settings
- Others
GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
